Ishita Drugs and Industries Limited (ISHITADR) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE806D01016
Key metrics
- Market Cap
- ₹22 Cr
- P/E Ratio
- 31.36
- EPS
- 2.36
- Book Value
- 38.69
- P/B Ratio
- 1.91
- ROE
- 6.73%
- ROCE
- 5.72%
- Debt / Equity
- 0.01
- Net Margin
- 5.31%
- Revenue Growth
- -2.25%
- Profit Growth
- -10.32%
- Dividend Yield
- —
- 52W High
- ₹90.85
- 52W Low
- ₹66.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Ishita Drugs and Industries Limited
Ishita Drugs and Industries Limited engages in the manufacture and sale of active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers Active Pharma Ingredients, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates and fine chemicals. The company was founded in 1972 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 58.99%
The full Ishita Drugs and Industries Limited analysis
Create a free account to open the complete ISHITADR deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.